Does BEVACIZUMAB Cause Neoplasm malignant? 308 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 308 reports of Neoplasm malignant have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.4% of all adverse event reports for BEVACIZUMAB.
308
Reports of Neoplasm malignant with BEVACIZUMAB
0.4%
of all BEVACIZUMAB reports
243
Deaths
34
Hospitalizations
How Dangerous Is Neoplasm malignant From BEVACIZUMAB?
Of the 308 reports, 243 (78.9%) resulted in death, 34 (11.0%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 308 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which BEVACIZUMAB Alternatives Have Lower Neoplasm malignant Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ